MDR1 P-glycoprotein transports endogenous opioid peptides
- 31 December 2001
- Vol. 22 (12), 2015-2020
- https://doi.org/10.1016/s0196-9781(01)00564-2
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathioneBiochemical Journal, 1999
- Linear and cyclic peptides as substrates and modulators of P-glycoprotein: peptide binding and effects on drug transport and accumulationBiochemical Journal, 1998
- The P-Glycoprotein Efflux Pump: How Does it Transport Drugs?The Journal of Membrane Biology, 1997
- A potent and selective endogenous agonist for the µ-opiate receptorNature, 1997
- Synthetic hydrophobic peptides are substrates for P-glycoprotein and stimulate drug transportBiochemical Journal, 1996
- Molecular biology and pharmacology of cloned opioid receptors 1The FASEB Journal, 1995
- Interaction of bioactive hydrophobic peptides with the human multidrug transporterThe FASEB Journal, 1994
- Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsCell, 1994
- Genetic transfer of non-P-glycoprotein-mediated multidrug resistance (MDR) in somatic cell fusion: dissection of a compound MDR phenotype.Proceedings of the National Academy of Sciences, 1992